BLUE vs. OMEX

In the year-to-date period, BLUE achieves a -40.41% return, which is significantly lower than OMEX's 8.57% return. Over the past 10 years, BLUE has underperformed OMEX with an annualized return of -46.19%, while OMEX has yielded a comparatively higher -19.14% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and Odyssey Marine Exploration, Inc. (OMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BLUE Sharpe Ratio is -0.45, which is lower than the OMEX Sharpe Ratio of -0.30. The chart below compares the historical Sharpe Ratios of BLUE and OMEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BLUE nor OMEX has paid dividends to shareholders.

The maximum BLUE drawdown since its inception was -99.89%, roughly equal to the maximum OMEX drawdown of -99.70%. Use the drawdown chart below to compare losses from any high point for BLUE and OMEX.

bluebird bio, Inc. (BLUE) has a higher volatility of 42.96% compared to Odyssey Marine Exploration, Inc. (OMEX) at 32.33%. This indicates that BLUE's price experiences larger fluctuations and is considered to be riskier than OMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between bluebird bio, Inc. and Odyssey Marine Exploration, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.